Difficulty: Medium
Average Score: 89%
Practice
A 56-year-old man came to the clinic with complaints of tremor, bradykinesia, and ├óÔé¼┼ôa feeling of persistent restlessness├óÔé¼┬Ø after beginning a new antipsychotic regimen 2 months ago. The patient has a history of schizophrenia and depression. He is afraid he may have Parkinson's syndrome. The doctor recommended cessation of the new regimen and assures the patient the symptoms will clear after a few weeks or months after withdrawal. What antipsychotic was the most likely to have caused the patient's symptoms?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Haloperidol. Haloperidol is a first-generation (typical) antipsychotic known to have a high risk of causing extrapyramidal symptoms (EPS) such as tremor, bradykinesia, and akathisia. These symptoms are characteristic of drug-induced Parkinsonism, which can be mistaken for Parkinson's disease. Haloperidol has a high affinity for dopamine D2 receptors in the basal ganglia, leading to its propensity to cause EPS.
Regarding the other options:
A) Aripiprazole is a third-generation (atypical) antipsychotic with a lower risk of causing EPS due to its unique mechanism of partial agonism at dopamine receptors.
B) Clozapine is also an atypical antipsychotic known for its lower risk of EPS, making it an unlikely culprit in this case.
D) Olanzapine, another atypical antipsychotic, has a lower risk of EPS compared to typical antipsychotics like haloperidol.
This case highlights the importance of understanding the pharmacology of CNS drugs, particularly the differences in side effect profiles among antipsychotics. It is crucial for healthcare providers to recognize and manage adverse effects promptly to ensure optimal patient care and outcomes in individuals with mental health conditions.
Regarding the other options:
A) Aripiprazole is a third-generation (atypical) antipsychotic with a lower risk of causing EPS due to its unique mechanism of partial agonism at dopamine receptors.
B) Clozapine is also an atypical antipsychotic known for its lower risk of EPS, making it an unlikely culprit in this case.
D) Olanzapine, another atypical antipsychotic, has a lower risk of EPS compared to typical antipsychotics like haloperidol.
This case highlights the importance of understanding the pharmacology of CNS drugs, particularly the differences in side effect profiles among antipsychotics. It is crucial for healthcare providers to recognize and manage adverse effects promptly to ensure optimal patient care and outcomes in individuals with mental health conditions.